Buda Juice, Inc.
BUDA NYSE Beverages Financials FY2024–FY2025
What Buda Juice, Inc. does
No business description yet.
- Legal name
- BUDA JUICE, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 26, 2026
- Accession · CIK
- 0001493152-26-012988
0002079720
Revenue and margins
Buda Juice, Inc. had $12.6M of revenue in fiscal 2025, up 11.8% on the year before.
Net income and earnings per share
From fiscal 2024 to 2025, diluted EPS grew 0.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $2.9M in fiscal 2025, 23.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Buda Juice, Inc. returned — to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Buda Juice, Inc. can carry it.
| Fiscal year end | FY24 | FY25 |
|---|---|---|
| Cash and short-term investments | $1.9M | $1.8M |
| Debt incl. finance leases | — | $0.6M |
| Net debt / EBITDA | — | −0.3x |
| Debt / equity | — | 0.2x |
| Current ratio | 4.7x | 5.5x |
| Quick ratio | 4.0x | 4.9x |
| Total assets | $3.7M | $5.0M |
| Total liabilities | $0.6M | $1.2M |
| Shareholders' equity | $3.2M | $3.7M |
| Net debt (− = net cash) | — | −$1.2M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY24 | FY25 |
|---|---|---|
| Net income is positive | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ |
| Return on assets rose | — | ✕ |
| Cash from operations exceeds net income | ✓ | ✕ |
| Debt fell relative to assets | — | — |
| Current ratio rose | — | ✓ |
| Share count didn't rise | — | ✓ |
| Gross margin rose | — | ✕ |
| Revenue rose relative to assets | — | ✕ |
| F-score | — / 3 | 4 / 8 |
| Accruals ratio | −10.7% | 8.8% |
| Altman Z'' | 13.59 | 12.10 |
2 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY24 | FY25 |
|---|---|---|
| Income statement | ||
| Revenue | $11.3M | $12.6M |
| Gross profit | $5.2M | $5.6M |
| Operating income | $3.4M | $3.4M |
| Income tax | — | $0.0M |
| Net income | $3.6M | $3.5M |
| Diluted EPS | $0.20 | $0.20 |
| Diluted shares | 0.00B | 0.00B |
| Cash flow | ||
| Cash from operations | $4.0M | $3.2M |
| Capital expenditure | $0.7M | $0.2M |
| Free cash flow | $3.3M | $2.9M |
| Depreciation and amortization | $0.3M | $0.2M |
| Balance sheet | ||
| Cash and short-term investments | $1.9M | $1.8M |
| Total debt | — | $0.6M |
| Current assets | $2.7M | $3.2M |
| Current liabilities | $0.6M | $0.6M |
| Inventory | $0.4M | $0.3M |
| Property and equipment, net | $1.0M | $1.0M |
| Total assets | $3.7M | $5.0M |
| Total liabilities | $0.6M | $1.2M |
| Shareholders' equity | $3.2M | $3.7M |
| Margins | ||
| Gross margin | 46.2% | 44.6% |
| Operating margin | 30.3% | 27.4% |
| EBITDA margin | 32.7% | 29.2% |
| Net margin | 31.7% | 28.0% |
| FCF margin | 29.2% | 23.0% |
| Returns | ||
| Return on capital | — | 107.1% |
| Return on capital employed | 108.1% | 78.7% |
| Return on equity | 113.2% | 102.5% |
| Return on assets | 95.8% | 81.2% |
| Return on tangible equity | 113.2% | 94.5% |
| Growth | ||
| Revenue growth | — | 11.8% |
| Net income growth | — | −1.1% |
| EPS growth | — | 0.0% |
| FCF growth | — | −11.7% |
| Share count change | — | 0.0% |
| Financial health | ||
| Net debt / EBITDA | — | −0.3x |
| Debt / equity | — | 0.2x |
| Current ratio | 4.7x | 5.5x |
| Quick ratio | 4.0x | 4.9x |
| Capital allocation | ||
| Capex / revenue | 6.1% | 2.0% |
| Quality scores | ||
| Piotroski F-score | — | 4.0 |
| Altman Z'' | 13.6 | 12.1 |
| Accruals ratio | −10.7% | 8.8% |
Source: SEC EDGAR XBRL filings (CIK 0002079720). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.